Omega Fund IV, L.P.'s Net Worth
$57 Million
Who is Omega Fund IV, L.P.?
Omega Fund IV, L.P. has an estimated net worth of $57 Million. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., Replimune Group, Inc., Translate Bio, Inc., Egalet Corp, and Paratek Pharmaceuticals, Inc..
SEC CIK
Omega Fund IV, L.P.'s CIK is 0001528382
Past Insider Trading and Trends
2018 was Omega Fund IV, L.P.'s most active year for acquiring shares with 10 total transactions. Omega Fund IV, L.P.'s most active month to acquire stocks was the month of June. 2021 was Omega Fund IV, L.P.'s most active year for disposing of shares, totalling 26 transactions. Omega Fund IV, L.P.'s most active month to dispose stocks was the month of October. 2018 saw Omega Fund IV, L.P. paying a total of $4,000,005.00 for 8,247,830 shares, this is the most they've acquired in one year. In 2021 Omega Fund IV, L.P. cashed out on 313,997 shares for a total of $11,307,914.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.58
InvestorOmega Fund IV, L.P. owns 693,272 units of Common Stock which is worth $402,097.76. In the year 2018 Omega Fund IV, L.P. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.39M |
—
|
—
| 1.39M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $10.88
InvestorOmega Fund IV, L.P. owns 4,673,380 units of Common Stock which is worth $50,846,374.40. In the year 2018 Omega Fund IV, L.P. filed a total of 20 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.94% | -90.00K |
$12.64 | -$1,495,112.88 | 9.44M |
Mar 14 - Mar 16
| |||
Form 4
| -0.94% | -45.42K |
$34.58 | -$1,570,679.30 | 4.76M |
Scheduled
|
Nov 19 - Nov 22
| ||
Form 4
| -0.05% | -2.59K |
$33.50 | -$86,899.00 | 4.81M |
Scheduled
|
Nov 16 - Nov 18
| ||
Form 4
| -0.05% | -2.59K |
$33.50 | -$86,899.00 | 4.81M |
Scheduled
|
Nov 16 - Nov 18
| ||
Form 4
| -0.50% | -24.02K |
$33.66 | -$808,412.22 | 4.81M |
Scheduled
|
Nov 12 - Nov 15
| ||
Form 4
| -0.38% | -18.29K |
$33.61 | -$614,725.69 | 4.84M |
Scheduled
|
Nov 10 - Nov 11
| ||
Form 4
| -0.23% | -11.35K |
$33.66 | -$382,207.02 | 4.85M |
Scheduled
|
Nov 8 - Nov 9
| ||
Form 4
| -0.63% | -31.02K |
$33.57 | -$1,041,020.50 | 4.87M |
Scheduled
|
Nov 4 - Nov 5
| ||
Form 4
| -0.25% | -12.17K |
$33.58 | -$408,702.18 | 4.9M |
Scheduled
|
Sep 23
| ||
Form 4
| -2.00% | -100.00K |
$32.99 | -$3,299,008.74 | 4.91M |
Scheduled
|
Sep 16 - Sep 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -0.10% | -5.25K |
$45.00 | -$236,205.00 | 5.14M |
Scheduled
|
Feb 8
| ||
Form 4
| -0.57% | -30.35K |
$45.42 | -$1,378,444.10 | 5.28M |
Scheduled
|
Jan 26
| ||
Form 4
| -0.21% | -11.36K |
$45.04 | -$511,657.57 | 5.31M |
Scheduled
|
Jan 22
| ||
Form 4
| -0.37% | -19.58K |
$45.10 | -$883,053.80 | 5.33M |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +4.31% | 220K |
$13.61 | $2,994,200.00 | 5.33M |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 4.85M |
$15.00 | $4,000,005.00 | 4.85M |
Jul 19 - Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Translate Bio, Inc. No price found
InvestorOmega Fund IV, L.P. owns 1,458,424 units of Common Stock. In the year 2018 Omega Fund IV, L.P. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.88M |
—
|
—
| 4.88M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Egalet Corp No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.33M |
$6.39 | $2,027,502.00 | 2.33M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Paratek Pharmaceuticals, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.65% | 461.54K |
$13.00 | $5,999,994.00 | 1.97M |
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||